These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 9041285)

  • 1. Psychiatric disorders in adult patients with early-treated phenylketonuria.
    Pietz J; Fätkenheuer B; Burgard P; Armbruster M; Esser G; Schmidt H
    Pediatrics; 1997 Mar; 99(3):345-50. PubMed ID: 9041285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural and emotional problems in early-treated adolescents with phenylketonuria in comparison with diabetic patients and healthy controls.
    Weglage J; Grenzebach M; Pietsch M; Feldmann R; Linnenbank R; Denecke J; Koch HG
    J Inherit Metab Dis; 2000 Jul; 23(5):487-96. PubMed ID: 10947203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study.
    Mastrangelo M; Chiarotti F; Berillo L; Caputi C; Carducci C; Di Biasi C; Manti F; Nardecchia F; Leuzzi V
    Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of patients treated for phenylketonuria (PKU). Results from the Prague PKU Center.
    Cechák P; Hejcmanová L; Rupp A
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S59-63. PubMed ID: 8828612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopathology of patients treated early for phenylketonuria: results of the German collaborative study of phenylketonuria.
    Burgard P; Armbruster M; Schmidt E; Rupp A
    Acta Paediatr Suppl; 1994 Dec; 407():108-10. PubMed ID: 7766943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intellectual development and academic achievement of children treated early for phenylketonuria.
    Berry HK; O'Grady DJ; Perlmutter LJ; Bofinger MK
    Dev Med Child Neurol; 1979 Jun; 21(3):311-20. PubMed ID: 467815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behaviour and school achievement in patients with early and continuously treated phenylketonuria.
    Stemerdink BA; Kalverboer AF; van der Meere JJ; van der Molen MW; Huisman J; de Jong LW; Slijper FM; Verkerk PH; van Spronsen FJ
    J Inherit Metab Dis; 2000 Sep; 23(6):548-62. PubMed ID: 11032330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of the brain in phenylketonuria.
    Cleary MA; Walter JH; Wraith JE; Jenkins JP; Alani SM; Tyler K; Whittle D
    Lancet; 1994 Jul; 344(8915):87-90. PubMed ID: 7912392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment.
    Battistini S; De Stefano N; Parlanti S; Federico A
    Funct Neurol; 1991; 6(2):177-80. PubMed ID: 1916459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylketonuria and its variants: observations on intellectual functioning.
    Netley C; Hanley WB; Rudner HL
    Can Med Assoc J; 1984 Oct; 131(7):751-5. PubMed ID: 6478363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.
    Moyle JJ; Fox AM; Arthur M; Bynevelt M; Burnett JR
    Neuropsychol Rev; 2007 Jun; 17(2):91-101. PubMed ID: 17410469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric disorders in adolescent and young adult patients with phenylketonuria.
    Manti F; Nardecchia F; Chiarotti F; Carducci C; Carducci C; Leuzzi V
    Mol Genet Metab; 2016 Jan; 117(1):12-8. PubMed ID: 26655635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive functioning in adults with phenylketonuria: Report of a 10-year follow-up.
    Feldmann R; Osterloh J; Onon S; Fromm J; Rutsch F; Weglage J
    Mol Genet Metab; 2019 Mar; 126(3):246-249. PubMed ID: 30598390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaching out to the lost generation of adults with early-treated phenylketonuria (PKU).
    Burton BK; Leviton L
    Mol Genet Metab; 2010; 101(2-3):146-8. PubMed ID: 20638310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emotional outcome of adolescents and young adults with early and continuously treated phenylketonuria.
    Sullivan JE
    J Pediatr Psychol; 2001 Dec; 26(8):477-84. PubMed ID: 11700332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychometry and psychological observations in early treated children with phenylketonuria (PKU) during 12 years (author's transl)].
    Knoll E; Wehle E; Thalhammer O
    Klin Padiatr; 1980 Nov; 192(6):599-607. PubMed ID: 7194401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.